Clinically, GLP-1 agonists appear to have a broadly beneficial impact on cancer prevention as supported by this report
Take 2 capsules daily, or as directed by your healthcare practitioner
Figure 1 shows the synergistic neuroprotective effects of G-CSF, GLP-1, and EPO
Compound Purity products are intended solely for laboratory research purposes and are not to be used for any other purposes, including but not limited to vitro diagnostic purpose, in food drugs, medical devices, or cosmetics for humans or animals or for commercial purposes
Path 2: Gradual taper and discontinuation For patients who have made substantial lifestyle changes and want to attempt life without medication, a structured taper offers the best chance of success